AI changes the evidence pattern, not the need for control.
GAMP 5 / AIModel boundary
State what the model does, what it does not do, and which regulated process it touches.
Data integrity
Input, output, audit trail, access, retention, and review must remain trustworthy.
Supplier leverage
Vendor evidence can support but not replace internal accountability.
Periodic review
AI behaviour, data drift, and system performance should feed continued suitability review.
AI governance must connect to existing regulated systems.
not isolatedGxP impact assessment
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
User requirement set
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Supplier assessment
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Risk and criticality assessment
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Validation/assurance plan
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Configuration specification
Connect this evidence to QMS, clinical, software, supplier, data, or lifecycle governance where applicable.
Current public sources for GAMP 5 / AI.
official firstThese links are the public source anchors for this workspace. Interpretation, checklists, and future assets should point back here before being reused outside iFeed.
ISPE GAMP 5 official publication page
Current · Source-owner page for GAMP 5. Public pages must not reproduce protected guidance content.
European Commission EudraLex Volume 4
Current · Official page for EU GMP chapters and annexes, including computerized-system context such as Annex 11.
EU GMP Annex 11 Computerised Systems
2011-06-30 · Public EU GMP source for computerized systems in GMP contexts.